Compound 5a

(R)-N-(4-bromophenyl)-2-(1-fluoroethyl)-5-(trifluoromethyl) benzamide

From: Controlling Pd(iv) reductive elimination pathways enables Pd(ii)-catalysed enantioselective C(sp3)−H fluorination

View in PubChem | MDL Molfile | Chemdraw file

Compound data: HPLC

Compound data: 1H NMR

Compound data: 13C NMR

Compound data: 19F NMR

Compound data: 19F NMR

Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.

General procedure C: For fluorination products that cannot be separated in chiral HPLC, the aldehyde moiety was transformed into an amide group as following: To a solution of 3 (0.05 mmol) in t-BuOH (0.5 mL) were added a solution of NaClO2 (13.6 mg, 0.15 mmol), NaH2PO4 (41.4 mg, 0.3 mmol) in water (0.5 mL) and 2-methylbut-2-ene (106 uL, 1 mmol). The reaction mixture was stirred for 1 h, and concentrated in vacuo. The crude residue was acidified with 1 N HCl (aq), extracted with DCM. The combined organic layers were dried with Na2SO4, filtered and concentrated in vacuo. Without further purification, the corresponding carboxylic acid was used directly in the next step. To a solution of carboxylic acid in DCM (2 mL) was added (COCl)2 (10 uL) and a drop of DMF at 0 oC. The mixture was stirred for 3 h at room temperature, and solvent was removed in vacuo. The residue was redissolved in DCM (2 mL), and 4-bromoaniline, triethylamine were added. The resulting mixture was stirred overnight at room temperature. Upon completion, the solution was washed with 1 N HCl (aq), sat. NaHCO3 (aq), and brine. The combined organic layers were dried with Na2SO4, filtered and concentrated in vacuo. The crude residue was purified on silica gel to give 5.5a was prepared from 3a following general procedure C described above (91% ee). The ee value was determined by HPLC analysis on a Chiralcel AS-H column (10% isopropanol in hexanes, 0.8 mL/min) with retention time of 13.6 min (minor) and 15.9 min (major). Absolute stereochemistry was confirmed via X-Ray analysis of the crystal obtained using DCM/pentane as recrystallization solvents. 1H NMR (600 MHz, CDCl3): δ 7.84 – 7.78 (m, 3H), 7.65 (br s, 1H), 7.51 (br s, 4H), 6.09 (dq, J = 47.5, 6.2 Hz, 1H), 1.73 (dd, J = 24.2, 6.4 Hz, 3H). 13C NMR (150 MHz, CDCl3): δ 165.37, 144.64 (d, J = 19.7 Hz), 136.30, 134.36 (d, J = 5.0 Hz), 132.24, 131.13 – 130.27 (m), 127.95 (q, J = 3.7 Hz), 127.17 (d, J = 9.8 Hz), 123.64 (q, J = 3.6 Hz), 123.40 (d, J = 272.6 Hz), 121.76, 118.01, 88.24 (d, J = 167.6 Hz), 23.07 (d, J = 24.7 Hz). 19F NMR (376 MHz, CDCl3): δ –62.99, –168.50. HRMS (ESI-TOF): m/z calculated for C16H13BrF4NO+ [M+H]+ 390.0111, found 390.0111